Skip to content

U.S. STEM CELL, INC.: 10-Q filed 2014-11-07

What U.S. STEM CELL, INC. reported in its quarterly report filed 2014-11-07 (fiscal Q3 2014): 32 published measures, 80 facts as tagged in accession 0001145443-14-001305.

This filing

Form
10-Q (quarterly report)
Filed
2014-11-07
Fiscal period
fiscal Q3 2014
Accession
0001145443-14-001305 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All U.S. STEM CELL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-09-30248,454USD
At 2013-12-3186,139USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-09-30-10,812,983USD
At 2013-12-31-13,747,076USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-09-3046,592USD
At 2013-12-3146,227USD
At 2013-09-306,684USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-07-02 to 2014-09-30-1,473,233USD91
2014-01-01 to 2014-09-30-1,247,199USD273
2013-07-01 to 2013-09-30-1,146,769USD92
2013-01-01 to 2013-09-30-2,416,000USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-09-308,121USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-09-30-119,428,182USD
At 2013-12-31-118,180,983USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-07-02 to 2014-09-30659,543,477shares91
2014-01-01 to 2014-09-30605,015,919shares273
2013-07-01 to 2013-09-30323,296,916shares92
2013-01-01 to 2013-09-30336,682,241shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-09-3013,431USD
At 2013-12-319,055USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-09-30407,616USD273
2013-01-01 to 2013-09-30102,674USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-07-02 to 2014-09-30-1,466,732USD91
2014-01-01 to 2014-09-30-2,545,703USD273
2013-07-01 to 2013-09-30-1,067,153USD92
2013-01-01 to 2013-09-30-2,190,385USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-09-30226,619USD
At 2013-12-3166,924USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-07-02 to 2014-09-30331,026USD91
2014-01-01 to 2014-09-301,035,118USD273
2013-07-01 to 2013-09-30208,914USD92
2013-01-01 to 2013-09-301,270,663USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-09-3010,336,315USD
At 2013-12-3113,429,404USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-09-302,068,256USD
At 2013-12-312,382,267USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-09-30153,863USD
At 2013-12-3119,913USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-07-02 to 2014-09-302,046,268USD91
2014-01-01 to 2014-09-304,109,567USD273
2013-07-01 to 2013-09-301,098,812USD92
2013-01-01 to 2013-09-302,246,365USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-07-02 to 2014-09-301,512,706USD91
2014-01-01 to 2014-09-303,182,397USD273
2013-07-01 to 2013-09-30940,354USD92
2013-01-01 to 2013-09-301,750,276USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-07-02 to 2014-09-308,581USD91
2014-01-01 to 2014-09-3033,916USD273
2013-07-01 to 2013-09-30158,381USD92
2013-01-01 to 2013-09-30494,762USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-09-30533,694,420shares
At 2013-12-31379,787,745shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-09-30107,851,505USD
At 2013-12-31103,819,119USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-09-30887,684USD
At 2013-12-31879,563USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-09-30874,253USD
At 2013-12-31870,508USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-09-308,404USD
At 2013-12-3110,160USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-09-302,291,809USD
At 2013-12-314,480,335USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-09-3026,164USD
At 2013-12-31784USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-07-02 to 2014-09-30-1,473,233USD91
2014-01-01 to 2014-09-30-1,247,199USD273
2013-07-01 to 2013-09-30-1,146,769USD92
2013-01-01 to 2013-09-30-2,416,000USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-01-01 to 2014-09-301,247,199USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-01-01 to 2014-09-303,745USD273
2013-01-01 to 2013-09-301,328USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-07-02 to 2014-09-30-6,501USD91
2014-01-01 to 2014-09-301,298,504USD273
2013-07-01 to 2013-09-30-79,616USD92
2013-01-01 to 2013-09-30-225,615USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-09-30428,251USD273
2013-01-01 to 2013-09-301,100,000USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-62,953USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30628,684USD273
2013-01-01 to 2013-09-30-76,240USD273

Inspect the source

Entity
U.S. STEM CELL, INC. / CIK 0001388319
Captured
SEC response SHA-256
c83c9b6b62cb6d0ac9467b796bc9189f06a9e6d58b9f0203325b2ebc08e0a04c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001388319.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))